A growing body of evidence suggests a role for PI3K/Akt signaling in the regulation of the inflammatory response in diseases including rheumatoid arthritis [20], multiple sclerosis [21], asthma [22], and atherosclerosis [23]. Here, AKT1 is linked to atherosclerosis.